Your browser doesn't support javascript.
Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020.
Nørgaard, Sarah K; Vestergaard, Lasse S; Nielsen, Jens; Richter, Lukas; Schmid, Daniela; Bustos, Natalia; Braye, Toon; Athanasiadou, Maria; Lytras, Theodore; Denissov, Gleb; Veideman, Tatjana; Luomala, Oskari; Möttönen, Teemu; Fouillet, Anne; Caserio-Schönemann, Céline; An der Heiden, Matthias; Uphoff, Helmut; Gkolfinopoulou, Kassiani; Bobvos, Janos; Paldy, Anna; Rotem, Naama; Kornilenko, Irene; Domegan, Lisa; O'Donnell, Joan; Donato, Francesca De; Scortichini, Matteo; Hoffmann, Patrick; Velez, Telma; England, Kathleen; Calleja, Neville; van Asten, Liselotte; Stoeldraijer, Lenny; White, Richard A; Paulsen, Trine H; da Silva, Susana P; Rodrigues, Ana P; Klepac, Petra; Zaletel, Metka; Fafangel, Mario; Larrauri, Amparo; León, Inmaculada; Farah, Ahmed; Galanis, Ilias; Junker, Christoph; Perisa, Damir; Sinnathamby, Mary; Andrews, Nick; O'Doherty, Mark G; Irwin, David; Kennedy, Sharon.
  • Nørgaard SK; EuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.
  • Vestergaard LS; EuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.
  • Nielsen J; EuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.
  • Richter L; Austrian Agency for Health and Food Safety, Vienna, Austria.
  • Schmid D; Austrian Agency for Health and Food Safety, Vienna, Austria.
  • Bustos N; Sciensano, Brussels, Belgium.
  • Braye T; Sciensano, Brussels, Belgium.
  • Athanasiadou M; Ministry of Health, Nicosia, Cyprus.
  • Lytras T; European University Cyprus, Nicosia, Cyprus.
  • Denissov G; National Institute for Health Development, Tallinn, Estonia.
  • Veideman T; National Institute for Health Development, Tallinn, Estonia.
  • Luomala O; Finnish National Institute for Health and Welfare, Helsinki, Finland.
  • Möttönen T; Finnish National Institute for Health and Welfare, Helsinki, Finland.
  • Fouillet A; French Public Health Agency (Santé Publique France), Saint-Maurice, France.
  • Caserio-Schönemann C; French Public Health Agency (Santé Publique France), Saint-Maurice, France.
  • An der Heiden M; Robert Koch Institute, Berlin, Germany.
  • Uphoff H; Hessisches Landesprüfungs- und Untersuchungsamt im Gesundheitswesen, Dillenburg, Germany.
  • Gkolfinopoulou K; Hellenic Centre for Disease Control and Prevention, Athens, Greece.
  • Bobvos J; National Public Health Center, Budapest, Hungary.
  • Paldy A; National Public Health Center, Budapest, Hungary.
  • Rotem N; Health & Vital Statistics Sector, Central Bureau of Statistics, Jerusalem, Israel.
  • Kornilenko I; Health & Vital Statistics Sector, Central Bureau of Statistics, Jerusalem, Israel.
  • Domegan L; Health Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.
  • O'Donnell J; Health Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.
  • Donato F; Dipartimento Epidemiologia del SSR, Lazio - ASL Roma 1, Rome, Italy.
  • Scortichini M; Dipartimento Epidemiologia del SSR, Lazio - ASL Roma 1, Rome, Italy.
  • Hoffmann P; Health Directorate Luxembourg - Division de l'inspection sanitaire, Luxembourg, Luxembourg.
  • Velez T; Health Directorate Luxembourg - Division de l'inspection sanitaire, Luxembourg, Luxembourg.
  • England K; Directorate for Health Information and Research, Pieta, Malta.
  • Calleja N; Directorate for Health Information and Research, Pieta, Malta.
  • van Asten L; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Stoeldraijer L; Statistics Netherlands, The Hague, the Netherlands.
  • White RA; Norwegian Institute of Public Health, Oslo, Norway.
  • Paulsen TH; Norwegian Institute of Public Health, Oslo, Norway.
  • da Silva SP; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
  • Rodrigues AP; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
  • Klepac P; National Institute of Public Health, Ljubljana, Slovenia.
  • Zaletel M; National Institute of Public Health, Ljubljana, Slovenia.
  • Fafangel M; National Institute of Public Health, Ljubljana, Slovenia.
  • Larrauri A; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.
  • León I; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.
  • Farah A; Public Health Agency of Sweden, Stockholm, Sweden.
  • Galanis I; Public Health Agency of Sweden, Stockholm, Sweden.
  • Junker C; Federal Statistical Office, Neuchâtel, Switzerland.
  • Perisa D; Federal Office of Public Health, Bern, Switzerland.
  • Sinnathamby M; Public Health England, Colindale, United Kingdom of Great Britain and Northern Ireland.
  • Andrews N; Public Health England, Colindale, United Kingdom of Great Britain and Northern Ireland.
  • O'Doherty MG; Public Health Agency, Northern Ireland, United Kingdom of Great Britain and Northern Ireland.
  • Irwin D; Public Health Agency, Northern Ireland, United Kingdom of Great Britain and Northern Ireland.
  • Kennedy S; Public Health Scotland, Glasgow, United Kingdom of Great Britain and Northern Ireland.
Euro Surveill ; 26(2)2021 01.
Article in English | MEDLINE | ID: covidwho-1067623
ABSTRACT
The European monitoring of excess mortality for public health action (EuroMOMO) network monitors weekly excess all-cause mortality in 27 European countries or subnational areas. During the first wave of the coronavirus disease (COVID-19) pandemic in Europe in spring 2020, several countries experienced extraordinarily high levels of excess mortality. Europe is currently seeing another upsurge in COVID-19 cases, and EuroMOMO is again witnessing a substantial excess all-cause mortality attributable to COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mortality / COVID-19 Type of study: Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged / Infant, Newborn / Young adult Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: 1560-7917.ES.2021.26.1.2002023

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mortality / COVID-19 Type of study: Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged / Infant, Newborn / Young adult Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: 1560-7917.ES.2021.26.1.2002023